Sandrine Pradel-Neuman and Eric Neuman*
Centre Vitruve, 23 rue Galilée, Paris, France
*Corresponding Author: Eric Neuman, Centre Vitruve, 23 rue Galilée, Paris, France.
Received: February 17, 2020; Published: May 11, 2020
During the last two years, in a multidisciplinary psychiatric practice, a psychiatrist assisted with a sleep therapist decided to demonstrates that the management of secondary insomnia (induced by sleep apnea/hypopnea syndrome (SAHS)) and some other primary sleep disorders, with specific sleep therapy can reduce or sometimes even stop antidepressant treatments when a welldefined protocol is followed. Their results confirmed that in some of their patients there may be SAHS in drug-resistant depressions. This point out the fact any depression syndromes are due to or aggravated by insomnia induced by SAHS. Taking care of it may replace antidepressants.
Keywords: Sleep Disorders; Depressive Syndrome; Drug Resistance
Citation: Sandrine Pradel-Neuman and Eric Neuman. “Interest of Screening and Management for Sleep Disorders in the Drug-Resistant Depressive Syndrome". Acta Scientific Medical Sciences 4.6 (2020): 32-36.
Copyright: © 2020 Sandrine Pradel-Neuman and Eric Neuman. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.